Found: 22
Select item for more details and to access through your institution.
Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis.
- Published in:
- Thrombosis, 2013, p. 1, doi. 10.1155/2013/563217
- By:
- Publication type:
- Article
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
- Published in:
- Vascular Health & Risk Management, 2012, v. 8, p. 45, doi. 10.2147/VHRM.S26482
- By:
- Publication type:
- Article
The population attributable risk of nutrition and lifestyle on hip fractures.
- Published in:
- Hip International, 2015, v. 25, n. 3, p. 277, doi. 10.5301/hipint.5000229
- By:
- Publication type:
- Article
The proportion of perioperative mortalities attributed to cemented implantation in hip fracture patients treated by hemiarthroplasty.
- Published in:
- Hip International, 2014, v. 24, n. 4, p. 363, doi. 10.5301/hipint.5000123
- By:
- Publication type:
- Article
Preoperative versus postoperative initiation of dalteparin thromboprophylaxis in THA.
- Published in:
- Hip International, 2010, v. 20, n. 3, p. 301, doi. 10.1177/112070001002000302
- By:
- Publication type:
- Article
Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials.
- Published in:
- Thrombosis Journal, 2015, v. 13, p. 1, doi. 10.1186/s12959-015-0067-8
- By:
- Publication type:
- Article
Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery [corrected].
- Published in:
- 2012
- By:
- Publication type:
- journal article
Clinical and biochemical prediction of early fatal outcome following hip fracture in the elderly.
- Published in:
- International Orthopaedics, 2011, v. 35, n. 6, p. 903, doi. 10.1007/s00264-010-1149-7
- By:
- Publication type:
- Article
Orthopaedic Surgery as a Model for Drug Development in Thrombosis.
- Published in:
- Drugs, 2004, v. 64, n. 1, p. 17, doi. 10.2165/00003495-200464001-00004
- By:
- Publication type:
- Article
Prevention of Venous Thromboembolism Following Orthopaedic Surgery: Clinical Potential of Direct Thrombin Inhibitors.
- Published in:
- Drugs, 2004, v. 64, n. 6, p. 577, doi. 10.2165/00003495-200464060-00002
- By:
- Publication type:
- Article
Orthopaedic Surgery as a Model for Drug Development in Thrombosis.
- Published in:
- Drugs, 2004, v. 64, p. 17, doi. 10.2165/00003495-200464001-00004
- By:
- Publication type:
- Article
Extended Out-of-Hospital Low-Molecular-Weight Heparin Prophylaxis against Deep Venous Thrombosis in Patients after Elective Hip Arthroplasty: A Systematic Review.
- Published in:
- Annals of Internal Medicine, 2001, v. 135, n. 10, p. 858, doi. 10.7326/0003-4819-135-10-200111200-00006
- By:
- Publication type:
- Article
Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery: Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.
- Published in:
- Clinical Drug Investigation, 2005, v. 25, n. 1, p. 65, doi. 10.2165/00044011-200525010-00006
- By:
- Publication type:
- Article
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery
- Published in:
- Clinical Pharmacokinetics, 2008, v. 47, n. 3, p. 203, doi. 10.2165/00003088-200847030-00006
- By:
- Publication type:
- Article
Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement.
- Published in:
- Journal of Clinical Pharmacology, 2005, v. 45, n. 5, p. 555, doi. 10.1177/0091270005274550
- By:
- Publication type:
- Article
Low-molecular-weight heparin for hip fracture patients treated with osteosynthesis: should thromboprophylaxis start before or after surgery? An observational study of 45,913 hip fractures reported to the Norwegian Hip Fracture Register.
- Published in:
- Acta Orthopaedica, 2018, v. 89, n. 6, p. 615, doi. 10.1080/17453674.2018.1519101
- By:
- Publication type:
- Article
Postoperative start compared to preoperative start of low-molecular-weight heparin increases mortality in patients with femoral neck fractures.
- Published in:
- Acta Orthopaedica, 2017, v. 88, n. 1, p. 48, doi. 10.1080/17453674.2016.1235427
- By:
- Publication type:
- Article
The Bone Cement Hypercoagulation Syndrome: Pathophysiology, Mortality, and Prevention.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231198036
- By:
- Publication type:
- Article
Thrombin Generation in Patients With Suspected Venous Thromboembolism.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2017, v. 23, n. 5, p. 416, doi. 10.1177/1076029617700999
- By:
- Publication type:
- Article
Clinical Venous Thromboembolism Following Joint Surgery: Effect of Extended Thromboprophylaxis on Its Annual Frequency and Postoperative Pattern Over 22 Years.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2014, v. 20, n. 2, p. 117, doi. 10.1177/1076029613499820
- By:
- Publication type:
- Article
Dabigatran Etexilate for the Prophylaxis of Venous Thromboembolism After Hip or Knee Replacement Rationale for Dose Regimen.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2009, v. 15, n. 1S, p. 17S, doi. 10.1177/1076029609344588
- By:
- Publication type:
- Article